PVCT Exercise Disclosure
Pershing Edward · SEC Form 4 · Filed Oct 30, 2026
Exercise
Calculated transaction value
$0
Pershing Edward CEO
PVCT
Transaction date
Oct 30, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed same day
PVCT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series D-1 Convertible Preferred Stock on Common Stock
- Quantity / price
- 24,544 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-049383
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. PVCT | Exercise | Oct 30, 2026 | Not reported |
| Provectus Biopharmaceuticals, Inc. PVCT Current | Exercise | Oct 30, 2026 | $0 |